GANCICLOVIR/ACYCLOVIR PROPHYLAXIS REDUCES THE INCIDENCE OF CYTOMEGALOVIRUS INFECTIONS IN PANCREAS TRANSPLANT RECIPIENTS

被引：0
|
作者：
HARLAND, RC
VERNON, WB
BUNZENDAHL, H
THOMPSON, JK
LAWRENCE, C
BOLLINGER, RR
机构：
来源：
TRANSPLANTATION PROCEEDINGS | 1994年 / 26卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：432 / 433
页数：2
相关论文
共 50 条
  • [41] Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study
    Maltazou, H
    Whimbey, E
    Abi-Said, D
    Przepiorka, D
    Champlain, R
    Goodrich, JM
    BONE MARROW TRANSPLANTATION, 1999, 24 (06) : 665 - 669
  • [42] Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study
    H Maltazou
    E Whimbey
    D Abi-Said
    D Przepiorka
    R Champlain
    JM Goodrich
    Bone Marrow Transplantation, 1999, 24 : 665 - 669
  • [43] Dosing of intravenous ganciclovir for prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients
    Fishman, JA
    Doran, MT
    Cosimi, AB
    Flood, JG
    Rubin, RH
    TRANSPLANTATION, 1999, 67 (07) : S99 - S99
  • [44] Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients - Is emergence of resistance imminent?
    Singh, N
    Yu, VL
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (06) : 1190 - 1192
  • [45] Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients
    Singh, N
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (05) : 742 - 751
  • [46] Acyclovir prophylaxis for cytomegalovirus disease in high-risk renal transplant recipients: Is it effective?
    Goral, S
    Ynares, C
    Dummer, S
    Helderman, JH
    KIDNEY INTERNATIONAL, 1996, 50 : S62 - S65
  • [47] Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients
    Gavalda, J
    deOtero, J
    Murio, E
    Vargas, V
    Rossello, J
    Calico, I
    Margarit, C
    Pahissa, A
    TRANSPLANT INTERNATIONAL, 1997, 10 (06) : 462 - 465
  • [48] Ganciclovir vs. valganciclovir for CMV prophylaxis in solitary pancreas transplant recipients.
    Rea, DJ
    Kudva, YC
    Larson, TS
    Stegall, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 380 - 380
  • [49] Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients
    Li, Fanny
    Kenyon, Kenneth W.
    Kirby, Katharine A.
    Fishbein, Daniel P.
    Boeckh, Michael
    Limaye, Ajit P.
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (04) : 439 - 447
  • [50] GANCICLOVIR TREATMENT OF CYTOMEGALOVIRUS INFECTIONS IN RENAL-TRANSPLANT RECIPIENTS - CLINICAL AND PHARMACOKINETIC STUDY
    RONDEAU, E
    FARQUET, C
    FRIES, D
    SRAER, JD
    PRESSE MEDICALE, 1991, 20 (40): : 2030 - 2032
12345